honokiol has been researched along with Diabetes Mellitus, Type 2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, Y; He, A; Hu, Y; Li, X; Luo, M; Lv, D; Sasmita, BR; Shen, J; Yu, H; Zhuang, R | 1 |
| Benigni, A; Bolognini, S; Cassis, P; Corna, D; Locatelli, M; Novelli, R; Perico, L; Remuzzi, G; Villa, S; Zanchi, C; Zoja, C | 1 |
| Aparicio, CNM; Heather, LC; Kerr, M; Miller, JJ; Scott, I; Stiewe, S; Thapa, D; Timm, KN; Tyler, DJ | 1 |
| Gopala, S; Jayakumari, NR; Parambil, ST; Rajendran, RS; Reghuvaran, AC; Sivasailam, A; Sreelatha, HV | 1 |
| Jiang, ZH; Li, CG; Li, CJ; Li, Z; Ni, CL; Sun, B; Tang, YZ; Yang, M; Zhu, YJ | 1 |
| Chen, Y; Wang, J; Zhai, T | 1 |
| Fu, X; Gao, X; Guo, Y; Hu, X; Huo, B; Li, W; Liu, Y; Sun, J; Wang, Y | 1 |
7 other study(ies) available for honokiol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Honokiol improves endothelial function in type 2 diabetic rats via alleviating oxidative stress and insulin resistance.
Topics: Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Insulin Resistance; Lignans; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Vascular Diseases; Vasodilation | 2022 |
Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents; Antioxidants; Biphenyl Compounds; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Kidney Glomerulus; Lignans; Male; Mice; Mice, Obese; Mitochondria; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Podocytes; Reactive Oxygen Species; Sirtuin 3; Superoxide Dismutase | 2020 |
Rescue of myocardial energetic dysfunction in diabetes through the correction of mitochondrial hyperacetylation by honokiol.
Topics: Acetylation; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Biphenyl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Energy Metabolism; Heart Diseases; Lignans; Male; Mitochondria, Heart; Myocardium; Phosphocreatine; Rats; Rats, Wistar | 2020 |
Honokiol regulates mitochondrial substrate utilization and cellular fatty acid metabolism in diabetic mice heart.
Topics: Acetylation; AMP-Activated Protein Kinases; Animals; Antioxidants; Biphenyl Compounds; CD36 Antigens; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Acids; Lignans; Male; Mice, Inbred C57BL; Mitochondria, Heart; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Streptozocin; Superoxide Dismutase | 2021 |
Honokiol protects pancreatic β cell against high glucose and intermittent hypoxia-induced injury by activating Nrf2/ARE pathway in vitro and in vivo.
Topics: Animals; Apoptosis; Biphenyl Compounds; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Free Radical Scavengers; Glucagon; Hypoxia; Insulin; Insulin Resistance; Insulin-Secreting Cells; Lignans; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sleep Apnea, Obstructive | 2018 |
Effects of Honokiol on CYP450 Activity and Transporter mRNA Expression in Type 2 Diabetic Rats.
Topics: Animals; Anion Transport Proteins; Biphenyl Compounds; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gastrointestinal Agents; Kidney; Lignans; Liver; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2018 |
Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Topics: Administration, Oral; Animals; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypoglycemic Agents; Injections, Intraperitoneal; Lignans; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Streptozocin; Structure-Activity Relationship | 2015 |